Modeling the Binding of Anticancer Peptides and Mcl-1
Shamsa Husain Ahmed Alhammadi1, Bincy Baby1, Priya Antony1
1Department of Biology, College of Science, United Arab Emirates University, Al Ain P.O. Box 15551, United Arab Emirates.
Abstract:
Mcl-1 (myeloid cell leukemia 1), a member of the Bcl-2 family, is upregulated in various types of cancer. Peptides representing the BH3 (Bcl-2 homology 3) region of pro-apoptotic proteins have been demonstrated to bind the hydrophobic groove of anti-apoptotic Mcl-1, and this interaction is responsible for regulating apoptosis. Structural studies have shown that, while there is high overall structural conservation among the anti-apoptotic Bcl-2 (B-cell lymphoma 2) proteins, differences in the surface groove of these proteins facilitates binding specificity. This binding specificity is crucial for the mechanism of action of the Bcl-2 family in regulating apoptosis. Bim-based peptides bind specifically to the hydrophobic groove of Mcl-1, emphasizing the importance of these interactions in the regulation of cell death. Molecular docking was performed with BH3-like peptides derived from Bim to identify high affinity peptides that bind to Mcl-1 and to understand the molecular mechanism of their interactions. The interactions of three identified peptides, E2gY, E2gI, and XXA1_F3dI, were further evaluated using 250 ns molecular dynamics simulations. Conserved hydrophobic residues of the peptides play an important role in their binding and the structural stability of the complexes. Understanding the molecular basis of interaction of these peptides will assist in the development of more effective Mcl-1 specific inhibitors.
Insights
Researchers identified specific peptides that bind to Mcl-1, a protein crucial in cancer cell survival. This discovery aids in developing targeted therapies by understanding how these peptides regulate apoptosis (programmed cell death).
Area of Science:
- Biochemistry
- Molecular Biology
- Cancer Research
Background:
- Mcl-1 (myeloid cell leukemia 1) is a Bcl-2 family protein often overexpressed in cancers.
- The interaction between Mcl-1 and BH3 (Bcl-2 homology 3) region peptides regulates apoptosis.
- Specific binding to Mcl-1's hydrophobic groove is key for therapeutic targeting.
Purpose of the Study:
- To identify high-affinity BH3-like peptides that bind to Mcl-1.
- To elucidate the molecular mechanisms underlying Mcl-1 and peptide interactions.
- To guide the development of novel Mcl-1 specific inhibitors.
Main Methods:
- Molecular docking simulations were used to identify potential binding peptides.
- BH3-like peptides derived from Bim were computationally screened.
- Molecular dynamics simulations (250 ns) analyzed the interactions of identified peptides (E2gY, E2gI, XXA1_F3dI).
Main Results:
- High-affinity peptides, including E2gY, E2gI, and XXA1_F3dI, were identified that bind to Mcl-1.
- Conserved hydrophobic residues within the peptides are critical for binding affinity and complex stability.
- The study provides detailed insights into the molecular interactions at the Mcl-1 binding interface.
Conclusions:
- Understanding the molecular basis of Mcl-1 and peptide interactions is essential for drug development.
- Targeting Mcl-1 with specific peptide inhibitors holds promise for cancer therapy.
- This research facilitates the design of more effective and selective Mcl-1 inhibitors.
More Related Videos
08:27Detection of Human Leukocyte Antigen Biomarkers in Breast Cancer Utilizing Label-free Biosensor Technology
Published on: March 24, 2015
11:58Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting
Published on: March 8, 2018
